IP Library Granted Patent US 9,416,364
Granted Patent B2
US 9,416,364 · App. 13/983,885 · Granted Aug 16, 2016

Reverse beta oxidation pathway

Inventors: Ramon Gonzalez (Houston, TX); James Clomburg (Houston, TX); Clementina Dellomonaco (Wilmington, DE); Elliot N. Miller (Houston, TX)
Assignee: William Marsh Rice University
C12N15/70C12P5/02C12P5/026C12P7/04C12P7/16C12P7/40C12P7/42C12P7/6409C12Y102/0105Y02E50/10Y02P20/52
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,416,364
App. No.
13/983,885
Granted
Aug 16, 2016
Kind
B2
Abstract

The invention relates to recombinant microorganisms that have been engineered to produce various chemicals using genes that have been repurposed to create a reverse beta oxidation pathway. Generally speaking, the beta oxidation cycle is expressed and driven in reverse by modifying various regulation points for as many cycles as needed, and then the CoA thioester intermediates are converted to useful products by the action of termination enzymes.

Claims (29)

1. An engineered microorganism, wherein the microorganism is engineered to overexpress β-oxidation cycle enzymes and one or more termination enzymes as compared to a corresponding wild-type microorganism, wherein said β-oxidation cycle enzymes comprise:

a) a thiolase catalyzing the conversion of (C n )-acyl CoA to β-ketoacyl-CoA,

b) a hydroxyacyl-CoA dehydrogenase catalyzing the conversion of β-ketoacyl-CoA to β-hydroxyacyl-CoA,

c) an enoyl-CoA hydratase catalyzing the conversion of β-hydroxyacyl-CoA to trans-Δ2-Enoyl-CoA, and

d) an acyl-CoA dehydrogenase or transenoyl-CoA reductase catalyzing the conversion of trans-Δ2-enoyl-CoA to (C n+2 )-acyl CoA,

wherein said β-oxidation cycle runs in the reverse/biosynthetic direction, as recited in enzyme reactions a) through d),

and

wherein said one or more termination enzymes are selected from the group consisting of an alcohol-forming coenzyme-A thioester reductase; an aldehyde-forming CoA thioester reductase and an alcohol dehydrogenase; a thioesterase; an acyl-CoA:acetyl-CoA transferase; a phosphotransacylase and a carboxylate kinase; an aldehyde-forming CoA thioester reductase and an aldehyde decarbonylase; and OleA, OleB, OleC, and OleD.

2. An engineered microorganism comprising a genotype, wherein said genotype comprises fadR, atoC(c), ΔarcA, Δcrp, crp*.

3. The engineered microorganism of claim 2 , wherein said genotype is selected from the group consisting of:

a) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔldhA, ΔmgsA, [tesB+];

b) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔldhA, ΔmgsA, [tesB+, yqeF+]; and

c) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔldhA, ΔmgsA, ΔfadB, [tesB+, yqeF+].

4. The engineered microorganism of claim 2 , wherein said genotype is selected from the group consisting of:

a) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔldhA, ΔmgsA, [tesA+];

b) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔldhA, ΔmgsA, [tesA+, yqeF+]; and

c) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔldhA, ΔmgsA, ΔydiO, [tesB+, yqeF+].

5. The engineered microorganism of claim 2 , wherein said genotype is selected from the group consisting of:

a) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, ΔydiO, [yqeF+, tesB+];

b) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, fadM+]; and

c) fadR, atoC(c), ΔarcA, Δcrp, crp, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, yciA+].

6. The engineered microorganism of claim 2 , wherein said genotype is selected from the group consisting of:

a) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [yqeF+, acrM+, PCC7942_orf1593+];

b) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [yqeF+, acrl+, PCC7942_orf1593+];

c) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [yqeF+, oleABCD+];

d) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, acrM+, PCC7942_orf1593+];

e) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, acrl+, PCC7942_orf1593+]; and

f) fadR, atoC(c), ΔarcA, Δcrp, crp*, ΔadhE, ΔfrdA, Δpta, ΔyqhA, ΔfucO, ΔfadD, [fadBA+, oleABCD+].

7. A method of making a product, said method comprising growing the engineered microorganism of claim 1 under microaerobic (<10% O 2 ) or anaerobic conditions in a glucose minimal medium supplemented with 0-100 μM FeSO 4 and 0-5 mM calcium pantothenate at a temperature of 30-40° C. for a time sufficient to allow production of a product and isolating said product, wherein said product is selected from the group consisting of trans Δ2 fatty alcohols, β-keto alcohols, 1-3 diols, β-hydroxy acids, carboxylic acids, and hydrocarbons.

Assignments (2)
CONFIRMATORY LICENSE Recorded May 8, 2015
From: RICE UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 035596/0075 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 25, 2013
From: GONZALEZ, RAMON; CLOMBURG, JAMES M.; DELLOMONACO, CLEMENTINA; MILLER, ELLIOT N.
To: WILLIAM MARSH RICE UNIVERSITY
Reel/Frame 031274/0068 →
Continuity (2)
Provisional Application 61440192 · Feb 7, 2011
Related Publication 20130316413A1 · Nov 28, 2013